Lisanti Capital Growth LLC Acquires Shares of 32,735 Doximity, Inc. (NASDAQ:DOCS)

Lisanti Capital Growth LLC bought a new stake in Doximity, Inc. (NASDAQ:DOCS - Free Report) during the first quarter, according to its most recent filing with the SEC. The firm bought 32,735 shares of the company's stock, valued at approximately $1,900,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of DOCS. Sanctuary Advisors LLC grew its stake in Doximity by 10.2% in the 4th quarter. Sanctuary Advisors LLC now owns 7,251 shares of the company's stock valued at $428,000 after buying an additional 672 shares during the last quarter. Truist Financial Corp acquired a new position in Doximity in the 4th quarter valued at $307,000. Global Retirement Partners LLC grew its stake in Doximity by 468.1% in the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock valued at $29,000 after buying an additional 440 shares during the last quarter. IFP Advisors Inc grew its stake in Doximity by 344.1% in the 4th quarter. IFP Advisors Inc now owns 1,328 shares of the company's stock valued at $71,000 after buying an additional 1,029 shares during the last quarter. Finally, Amalgamated Bank grew its stake in Doximity by 2.3% in the 4th quarter. Amalgamated Bank now owns 60,742 shares of the company's stock valued at $3,243,000 after buying an additional 1,343 shares during the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Doximity Stock Performance

Shares of NASDAQ:DOCS traded up $0.78 during midday trading on Friday, reaching $61.19. 4,819,229 shares of the company's stock were exchanged, compared to its average volume of 2,172,364. The company's 50 day simple moving average is $56.21 and its two-hundred day simple moving average is $58.78. The firm has a market capitalization of $11.49 billion, a PE ratio of 61.19, a price-to-earnings-growth ratio of 4.10 and a beta of 1.33. Doximity, Inc. has a 12 month low of $25.00 and a 12 month high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last announced its earnings results on Thursday, May 15th. The company reported $0.38 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.27 by $0.11. Doximity had a net margin of 36.60% and a return on equity of 21.75%. The firm's quarterly revenue was up 17.1% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.25 earnings per share. On average, research analysts anticipate that Doximity, Inc. will post 0.99 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on DOCS shares. KeyCorp lowered their target price on shares of Doximity from $83.00 to $70.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. Bank of America increased their price target on shares of Doximity from $55.00 to $62.00 and gave the company a "neutral" rating in a report on Wednesday. BTIG Research raised shares of Doximity from a "neutral" rating to a "buy" rating and set a $80.00 price target for the company in a report on Monday, June 2nd. Robert W. Baird reduced their price target on shares of Doximity from $87.00 to $65.00 and set an "outperform" rating for the company in a report on Tuesday, May 20th. Finally, William Blair reissued an "outperform" rating on shares of Doximity in a report on Friday, May 16th. Eleven investment analysts have rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $63.11.

Insider Buying and Selling

In related news, Director Timothy S. Cabral sold 10,000 shares of the stock in a transaction dated Wednesday, June 25th. The shares were sold at an average price of $60.00, for a total transaction of $600,000.00. Following the completion of the sale, the director now owns 6,360 shares in the company, valued at $381,600. This trade represents a 61.12% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Kira Scherer Wampler sold 2,000 shares of the firm's stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $56.93, for a total transaction of $113,860.00. Following the completion of the sale, the director now owns 16,618 shares of the company's stock, valued at $946,062.74. The trade was a 10.74% decrease in their position. The disclosure for this sale can be found here. Insiders sold 71,000 shares of company stock worth $4,100,770 in the last quarter. 37.40% of the stock is owned by corporate insiders.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.